Payment overview · 2025
General Payments
4 reported records · 3 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · ANNISTON, AL · NPI 1669496527
Verified facts
CMS Open Payments records show Michael Hanna, M.D. received $77.41 in general payments during 2025 across 4 reported records.
UCB, Inc. accounted for 43.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
4 reported records · 3 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| UCB, Inc. | Unresolved — no canonical attribution shown | $33.92 | 43.8% | 2 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $24.37 | 31.5% | 1 | 2025 |
| KYOWA KIRIN, INC. | Unresolved — no canonical attribution shown | $19.12 | 24.7% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $77.41 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Bimzelx Normalized: bimzelx |
Biological | UCB, Inc. | $33.92 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $24.37 | 1 | 2025 |
Source payment records
|
|||||
| CRYSVITA Normalized: crysvita |
Drug | KYOWA KIRIN, INC. | $19.12 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 12 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1306 | 184 |
| Gabapentin | Gabapentin | 937 | 111 |
| Furosemide | Furosemide | 931 | 99 |
| Eliquis | Apixaban | 843 | 77 |
| Amlodipine Besylate | Amlodipine Besylate | 749 | 145 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 661 | 108 |
| Levothyroxine Sodium | Levothyroxine Sodium | 637 | 92 |
| Potassium Chloride | Potassium Chloride | 555 | 83 |
| Omeprazole | Omeprazole | 541 | 92 |
| Losartan Potassium | Losartan Potassium | 535 | 122 |
| Sertraline Hcl | Sertraline Hcl | 489 | 68 |
| Carvedilol | Carvedilol | 479 | 70 |
| Trazodone Hcl | Trazodone Hcl | 440 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 419 | 69 |
| Lisinopril | Lisinopril | 396 | 71 |
| Famotidine | Famotidine | 380 | 67 |
| Quetiapine Fumarate | Quetiapine Fumarate | 380 | 55 |
| Buspirone Hcl | Buspirone Hcl | 367 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 353 | 89 |
| Metformin Hcl | Metformin Hcl | 316 | 45 |
| Metoprolol Tartrate | Metoprolol Tartrate | 316 | 55 |
| Clopidogrel | Clopidogrel Bisulfate | 306 | 51 |
| Donepezil Hcl | Donepezil Hcl | 291 | 43 |
| Mirtazapine | Mirtazapine | 285 | 58 |
| Levetiracetam | Levetiracetam | 277 | 28 |
| Sucralfate | Sucralfate | 267 | 35 |
| Citalopram Hbr | Citalopram Hydrobromide | 263 | 32 |
| Ondansetron Hcl | Ondansetron Hcl | 241 | 70 |
| Divalproex Sodium | Divalproex Sodium | 239 | 29 |
| Tramadol Hcl | Tramadol Hcl | 230 | 48 |
| Duloxetine Hcl | Duloxetine Hcl | 225 | 30 |
| Metoprolol Succinate | Metoprolol Succinate | 222 | 35 |
| Olanzapine | Olanzapine | 217 | 13 |
| Risperidone | Risperidone | 213 | suppressed |
| Alprazolam | Alprazolam | 202 | 27 |
| Montelukast Sodium | Montelukast Sodium | 195 | 49 |
| Simvastatin | Simvastatin | 178 | 33 |
| Memantine Hcl | Memantine Hcl | 174 | 31 |
| Spironolactone | Spironolactone | 174 | 19 |
| Lorazepam | Lorazepam | 172 | 31 |
| Pravastatin Sodium | Pravastatin Sodium | 163 | 33 |
| Hydralazine Hcl | Hydralazine Hcl | 154 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 154 | 39 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 153 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 151 | 42 |
| Allopurinol | Allopurinol | 150 | 23 |
| Clonazepam | Clonazepam | 146 | 21 |
| Lubiprostone | Lubiprostone | 144 | 11 |
| Lamotrigine | Lamotrigine | 138 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 133 | 19 |
| Dicyclomine Hcl | Dicyclomine Hcl | 126 | 18 |
| Clonidine Hcl | Clonidine Hcl | 125 | 40 |
| Azithromycin | Azithromycin | 117 | 87 |
| Escitalopram Oxalate | Escitalopram Oxalate | 115 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 115 | 17 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 113 | 59 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 111 | 24 |
| Baclofen | Baclofen | 107 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 102 | 20 |
| Ramelteon | Ramelteon | 101 | 15 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 98 | 15 |
| Fenofibrate | Fenofibrate | 94 | 17 |
| Meloxicam | Meloxicam | 93 | 25 |
| Amiodarone Hcl | Amiodarone Hcl | 91 | 19 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 87 | 11 |
| Entresto | Sacubitril/Valsartan | 87 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 85 | 29 |
| Xarelto | Rivaroxaban | 84 | 12 |
| Fenofibrate | Fenofibrate Nanocrystallized | 82 | suppressed |
| Atenolol | Atenolol | 80 | 11 |
| Mupirocin | Mupirocin | 79 | 39 |
| Zolpidem Tartrate | Zolpidem Tartrate | 79 | 20 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 75 | 29 |
| Jardiance | Empagliflozin | 74 | suppressed |
| Cilostazol | Cilostazol | 73 | 12 |
| Pregabalin | Pregabalin | 72 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 70 | 25 |
| Latanoprost | Latanoprost | 64 | 17 |
| Ranolazine Er | Ranolazine | 61 | suppressed |
| Colchicine | Colchicine | 60 | 13 |
| Trulicity | Dulaglutide | 60 | suppressed |
| Aripiprazole | Aripiprazole | 58 | suppressed |
| Fluconazole | Fluconazole | 58 | 31 |
| Fluoxetine Hcl | Fluoxetine Hcl | 58 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 58 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 57 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 56 | 17 |
| Promethazine Hcl | Promethazine Hcl | 55 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 54 | 14 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 54 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 53 | 24 |
| Cyclosporine | Cyclosporine | 53 | suppressed |
| Levofloxacin | Levofloxacin | 53 | 37 |
| Misoprostol | Misoprostol | 52 | suppressed |
| Prednisone | Prednisone | 52 | 27 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 51 | 13 |
| Diltiazem Hcl | Diltiazem Hcl | 51 | suppressed |
| Levemir | Insulin Detemir | 51 | suppressed |
| Ozempic | Semaglutide | 50 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 49 | 36 |
| Diazepam | Diazepam | 48 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 48 | 32 |
| Insulin Aspart | Insulin Aspart | 47 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 47 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 46 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 46 | 36 |
| Nadolol | Nadolol | 45 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 45 | 15 |
| Brilinta | Ticagrelor | 44 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 44 | suppressed |
| Bupropion Xl | Bupropion Hcl | 43 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 42 | 12 |
| Myrbetriq | Mirabegron | 42 | suppressed |
| Methocarbamol | Methocarbamol | 41 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 41 | 11 |
| Nystatin | Nystatin | 41 | 25 |
| Lacosamide | Lacosamide | 40 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 40 | 11 |
| Celecoxib | Celecoxib | 39 | 12 |
| Farxiga | Dapagliflozin Propanediol | 39 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 39 | 11 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 39 | suppressed |
| Carbidopa-Levodopa-Entacapone | Carbidopa/Levodopa/Entacapone | 38 | suppressed |
| Levemir Flexpen | Insulin Detemir | 38 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 38 | 17 |
| Warfarin Sodium | Warfarin Sodium | 37 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 35 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Linzess | Linaclotide | 35 | 12 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 34 | 34 |
| Nystop | Nystatin | 34 | 15 |
| Lactulose | Lactulose | 33 | suppressed |
| Topiramate | Topiramate | 33 | suppressed |
| Ezetimibe | Ezetimibe | 32 | 11 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 32 | 32 |
| Benztropine Mesylate | Benztropine Mesylate | 30 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 30 | 21 |
| Ertapenem | Ertapenem Sodium | 30 | suppressed |
| Fentanyl | Fentanyl | 30 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 29 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | 12 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 29 | suppressed |
| Ketoconazole | Ketoconazole | 29 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 29 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 28 | 11 |
| Finasteride | Finasteride | 26 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 26 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 26 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 26 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 25 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 25 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 25 | suppressed |
| Estradiol | Estradiol | 25 | suppressed |
| Glucagon Emergency Kit | Glucagon | 25 | 15 |
| Nifedipine Er | Nifedipine | 25 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 25 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 24 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 24 | suppressed |
| Repatha Sureclick | Evolocumab | 24 | suppressed |
| Ursodiol | Ursodiol | 24 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 23 | suppressed |
| Glimepiride | Glimepiride | 23 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 21 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 21 | suppressed |
| Valproic Acid | Valproic Acid | 21 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 21 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Budesonide | Budesonide | 20 | 12 |
| Calcitriol | Calcitriol | 20 | suppressed |
| Calcium Acetate | Calcium Acetate | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 20 | suppressed |
| Sotalol | Sotalol Hcl | 20 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 19 | suppressed |
| Cefdinir | Cefdinir | 19 | 15 |
| Clonidine | Clonidine | 19 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 19 | suppressed |
| Irbesartan | Irbesartan | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Perphenazine | Perphenazine | 19 | suppressed |
| Primidone | Primidone | 19 | suppressed |
| Restasis | Cyclosporine | 19 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Enulose | Lactulose | 18 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 18 | 12 |
| Methotrexate | Methotrexate Sodium | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 18 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 17 | 15 |
| Clozapine | Clozapine | 17 | suppressed |
| Daptomycin-0.9% Nacl | Daptomycin In 0.9 % Sod Chlor | 17 | suppressed |
| Ibuprofen | Ibuprofen | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Metronidazole | Metronidazole | 17 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 17 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 17 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Amoxicillin | Amoxicillin | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | 14 |
| Entacapone | Entacapone | 16 | suppressed |
| Gemtesa | Vibegron | 16 | suppressed |
| Haloperidol | Haloperidol | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Indapamide | Indapamide | 16 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 16 | 15 |
| Nyamyc | Nystatin | 16 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 15 | 12 |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Modafinil | Modafinil | 15 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 15 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 15 | suppressed |
| Premarin | Estrogens, Conjugated | 15 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 14 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | 12 |
| Mounjaro | Tirzepatide | 14 | suppressed |
| Onglyza | Saxagliptin Hcl | 14 | suppressed |
| Travoprost | Travoprost | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Edarbi | Azilsartan Medoxomil | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Meropenem | Meropenem | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Dextrose In Water | Dextrose 5 % In Water | 12 | suppressed |
| Norethindrone Acetate | Norethindrone Acetate | 12 | suppressed |
| Oxazepam | Oxazepam | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Thiothixene | Thiothixene | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 11 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 11 | suppressed |
| Sulfasalazine | Sulfasalazine | 11 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $77.41 · 4 records | UCB, Inc. | Bimzelx, CRYSVITA, REXULTI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error